Interpace Biosciences IDXG
OTC IDXG
$6.00 -0.39 (-6.10%)
At close: Oct 2, 2026 · 4:00 PM EDT

Interpace Biosciences (IDXG) Return on Equity [ROE] (2011 - 2026)

Updated

Interpace Biosciences (IDXG) posted Return on Equity [ROE] of 105.55% for Q2 2026, up 1.47 percentage points from the prior quarter.

Analysis

Interpace Biosciences (IDXG) Return on Equity [ROE] (2011 - 2026) Analysis & Trends

For FY2025, Interpace Biosciences' Return on Equity [ROE] came in at 243.97%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 HCA Healthcare 93.08 Bn 92.52 Bn - -
2 Natera 58.93 Bn 54.61 Bn 485.19 Mn -10.70%
3 Quest Diagnostics 25.75 Bn 24.18 Bn 1.03 Bn 14.38%
4 Labcorp Holdings 24.96 Bn 22.73 Bn 1.11 Bn 11.58%
5 Guardant Health 23.76 Bn 19.82 Bn 219.03 Mn -
6 Tenet Healthcare 20.83 Bn 11.98 Bn - 47.84%
7 Tempus AI 13.43 Bn 10.46 Bn 246.50 Mn -57.32%
8 BrightSpring Health Services 11.90 Bn 10.24 Bn 492.75 Mn 18.16%
9 Encompass Health 11.82 Bn 12.29 Bn - 24.83%
10 Interpace Biosciences 166.21 Mn 156.93 Mn 5.65 Mn 105.55%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 105.55%
Mar 31, 2026 104.08%
Dec 31, 2025 220.32%
Dec 31, 2019 -3,447.97%
Sep 30, 2019 -212.91%
Jun 30, 2019 -102.30%
Mar 31, 2019 -75.91%
Dec 31, 2018 -74.19%
Sep 30, 2018 -65.46%
Jun 30, 2018 -60.91%
Mar 31, 2018 -78.18%
Dec 31, 2017 -57.66%
Sep 30, 2017 -4.75%
Jun 30, 2017 -37.29%
Jun 30, 2016 -223.46%
Mar 31, 2016 -164.83%
Dec 31, 2015 -216.80%
Sep 30, 2015 -450.34%
Jun 30, 2015 -220.08%
Mar 31, 2015 -124.66%
API Access

Interpace Biosciences Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=IDXG&period=max&api_key=YOUR_API_KEY